A 38-year-old woman from Mumbai with a history of myasthenia gravis presents with progressive weakness and ptosis. She is started on neostigmine, an acetylcholinesterase inhibitor. Two hours after the first dose, she develops muscle fasciculations, increased salivation, and bronchospasm. A colleague suggests that the drug has caused excessive depolarization at the neuromuscular junction. Which of the following best describes the ionic mechanism underlying the fasciculations observed in this patient?

Explanation

## Mechanism of Fasciculations in Cholinergic Excess ### Normal Neuromuscular Junction Physiology **Key Point:** At the neuromuscular junction, acetylcholine (ACh) binds to nicotinic receptors on the motor end plate, opening Na+ and K+ channels. The net inward Na+ current depolarizes the membrane, generating an end-plate potential (EPP). When the EPP exceeds threshold (typically −55 mV), an action potential is triggered in the muscle fiber. ### Pathophysiology of Neostigmine Overdose 1. **Acetylcholinesterase Inhibition:** Neostigmine blocks the enzyme that breaks down ACh, causing ACh to accumulate in the synaptic cleft. 2. **Prolonged Receptor Activation:** Sustained ACh binding keeps the nicotinic channels open longer than normal. 3. **Sustained Depolarization:** The motor end plate remains depolarized (at approximately −20 to −30 mV instead of returning to resting potential of −90 mV). 4. **Repetitive Firing:** While the muscle fiber is depolarized, voltage-gated Na+ channels undergo repeated cycles of inactivation and recovery, generating repetitive action potentials. 5. **Visible Fasciculations:** These repetitive action potentials cause visible, uncoordinated muscle contractions (fasciculations). ### Ionic Basis of Fasciculations ```mermaid flowchart TD A["Neostigmine blocks AChE"]:::action --> B["ACh accumulates in synaptic cleft"]:::outcome B --> C["Prolonged nicotinic receptor activation"]:::outcome C --> D["Motor end plate remains depolarized"]:::outcome D --> E{"Is membrane potential below threshold?"}:::decision E -->|Yes| F["Voltage-gated Na+ channels inactivate"]:::outcome F --> G["Channels recover from inactivation"]:::outcome G --> H["Repetitive action potentials generated"]:::outcome H --> I["Visible muscle fasciculations"]:::outcome E -->|No| J["No action potential"]:::outcome ``` **Clinical Pearl:** Fasciculations are a sign of depolarizing neuromuscular blockade (like succinylcholine) or cholinergic excess. They represent the muscle's attempt to repolarize and fire repeatedly while held in a partially depolarized state. **High-Yield:** The sequence in cholinergic crisis is: 1. **Fasciculations** (early, depolarization block) 2. **Flaccid paralysis** (late, desensitization block—the receptor becomes refractory to ACh despite continued stimulation) This patient's fasciculations indicate she is in the early phase of cholinergic toxicity. ### Why Fasciculations Occur (Not Paralysis Initially) During sustained depolarization, the muscle fiber is held near threshold. The repeated recovery of inactivated Na+ channels allows the fiber to fire action potentials. This is different from true paralysis, which occurs later when desensitization (a conformational change in the ACh receptor) prevents further channel opening despite ACh presence.